- $6.64bn
- $5.64bn
- $1.83bn
- 88
- 34
- 88
- 79
Annual cashflow statement for Exelixis, fiscal year end - December 29th, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 30th | 2023 December 29th | |
|---|---|---|---|---|---|
| Period Length: | 52 W | 52 W | 52 W | 52 W | 52 W |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 321 | 112 | 231 | 182 | 208 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 59.5 | 113 | 149 | 233 | 247 |
| Purchased R&D | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 67.1 | -40.1 | -39 | -12.8 | -14 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 527 | 209 | 401 | 363 | 333 |
| Capital Expenditures | -12.8 | -30.3 | -64.2 | -27.7 | -40.5 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -574 | -101 | 21.3 | -497 | 13.5 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -587 | -131 | -42.9 | -524 | -27 |
| Financing Cash Flow Items | -9.95 | -50 | -39.1 | — | -29.1 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 12.6 | -25.1 | -14.8 | 0.586 | -546 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -47.7 | 52.6 | 343 | -161 | -240 |